Yim, Hyung Joon <br/><br/>
Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 Trial.  [electronic resource] 

 -  The American journal of gastroenterology  08 2020 
 - 1217-1225 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1572-0241 
<br/><br/><label>Standard No.: </label>10.14309/ajg.0000000000000605  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--administration & dosage<br/>Bone Density<br/>Double-Blind Method<br/>Drug Administration Schedule<br/>Female<br/>Guanine--administration & dosage<br/>Hepatitis B virus<br/>Hepatitis B, Chronic--blood<br/>Humans<br/>Male<br/>Middle Aged<br/>Organophosphonates--administration & dosage<br/>Republic of Korea<br/>Tenofovir--administration & dosage<br/>Treatment Outcome<br/>Viral Load